Pulmonary hypertension due to myeloproliferative disorders (Q104911): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/1620664579 / rank | |||
Normal rank | |||
Revision as of 10:46, 17 August 2026
This is an increase of blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, together known as the lung vasculature, leading to shortness of breath, dizziness, fainting, and other symptoms, all of which are exacerbated by exertion, due to myeloproliferative disorders.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1620664579 |
||
| English | Pulmonary hypertension due to myeloproliferative disorders |
This is an increase of blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, together known as the lung vasculature, leading to shortness of breath, dizziness, fainting, and other symptoms, all of which are exacerbated by exertion, due to myeloproliferative disorders. |
